Financial MarketsInvesting.comThu, Sep 4, 2025, 1:32 PMNegative

Sanofi stock may face pressure as amlitelimab efficacy falls below expectations

Sanofi's stock is likely to experience pressure as the efficacy of its drug amlitelimab has fallen below market expectations.

Sanofi stock may face pressure as amlitelimab efficacy falls below expectations

WPN Brief

Sanofi's stock is likely to experience pressure as the efficacy of its drug amlitelimab has fallen below market expectations.
Ask WPN AI